Showing 1 to 2 of 2 results


Gabapentin Linked to Increased Dementia Risk in Back Pain Patients
A study of 1.4 million patients with back pain found those prescribed gabapentin had a significantly higher risk of developing dementia (up to 40 percent) and mild cognitive impairment (85 percent) compared to those who did not take the drug; however, researchers note this is an observational study ...
Gabapentin Linked to Increased Dementia Risk in Back Pain Patients
A study of 1.4 million patients with back pain found those prescribed gabapentin had a significantly higher risk of developing dementia (up to 40 percent) and mild cognitive impairment (85 percent) compared to those who did not take the drug; however, researchers note this is an observational study ...
Progress
40% Bias Score

FDA Approves Non-Addictive Pain Pill Journavx
The U.S. Food and Drug Administration approved Vertex Pharmaceuticals' Journavx, a non-addictive pain medication, for short-term pain relief following surgery or injury; studies showed modest effectiveness compared to opioids, but its different mechanism offers a new approach, although its $15.50 pr...

FDA Approves Non-Addictive Pain Pill Journavx
The U.S. Food and Drug Administration approved Vertex Pharmaceuticals' Journavx, a non-addictive pain medication, for short-term pain relief following surgery or injury; studies showed modest effectiveness compared to opioids, but its different mechanism offers a new approach, although its $15.50 pr...
Progress
40% Bias Score
Showing 1 to 2 of 2 results